Many mutations in one clinical-trial basket

Elaine Mardis ()

Nature, 2018, vol. 554, issue 7691, 173-175

Abstract: When abnormality in a gene is linked to cancer and a drug targets the encoded protein, how can the patients who will respond to the drug be identified if the gene is mutated in many different ways in many different cancers?

Keywords: Medical research; Cancer (search for similar items in EconPapers)
Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-018-01312-x Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:554:y:2018:i:7691:d:10.1038_d41586-018-01312-x

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-018-01312-x

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().